Altimmune (ALT) Total Debt (2012 - 2026)

Altimmune (ALT) has 14 years of Total Debt data on file, last reported at $34.5 million in Q1 2026.

• Total Debt for Q1 2026 came in at $34.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $34.5 million (changed N/A YoY), and the FY2025 annual result was $34.3 million, changed N/A from the prior year.
• Total Debt improved to $34.5 million in Q1 2026 per ALT's latest filing, from $34.3 million in the prior quarter.
• Over five years, Total Debt peaked at $34.5 million in Q1 2026 and troughed at $1.5 million in Q2 2022.
• A 4-year average of $11.5 million and a median of $4.6 million in 2022 frame the typical range for Total Debt.
• On a YoY basis, Total Debt climbed as much as 247.67% in 2022 and fell as far as 39.28% in 2022.
• A 4-year view of Total Debt shows it stood at $4.6 million in 2022, then dropped by 6.02% to $4.3 million in 2023, then surged by 696.45% to $34.3 million in 2025, then rose by 0.64% to $34.5 million in 2026.
• Business Quant data shows ALT's Total Debt at $34.5 million in Q1 2026, $34.3 million in Q4 2025, and $14.4 million in Q3 2025.